| 1 |
2024 |
Ye Gu, Qiang Liu, Qiaoxian He, Qiangsheng Wu, Lingyun Li, Dongchao Xu, Liyun Zheng, Lu Xie, Sile Cheng, Hongzhang Shen, Yifeng Zhou, Jianfeng Yang, Hangbin Jin, Xiaofeng Zhang. LC3-dependent extracellular vesicles promote M-MDSC accumulation and immunosuppression in colorectal cancer, iScience. 2024; 27: 109272109272.
https://doi.org/10.1016/j.isci.2024.109272 |
| 2 |
2024 |
Chun Ye, Xiao Liu, Zilun Liu, Chuxuan Pan, Xiaowei Zhang, Zhanyi Zhao, Haitao Sun. Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance, Cancer Biology & Therapy. 2024; 25: 2306676.
https://doi.org/10.1080/15384047.2024.2306676 |
| 3 |
2025 |
Qingzhe Wang, Min Yu, Shuang Zhang. The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies, Frontiers in Immunology. 2025; 15: 1440830.
https://doi.org/10.3389/fimmu.2024.1440830 |
| 4 |
2024 |
Nicola Normanno, Vincenza Caridi, Matteo Fassan, Antonio Avallone, Fortunato Ciardiello, Carmine Pinto. Resistance to immune checkpoint inhibitors in colorectal cancer with deficient mismatch repair/microsatellite instability: misdiagnosis, pseudoprogression and/or tumor heterogeneity?, Exploration of Targeted Anti-tumor Therapy. 2024; 5: 495.
https://doi.org/10.37349/etat.2024.00231 |
| 5 |
2024 |
Brett Bell, Kevin Flores-Lovon, Luis A. Cueva-Chicaña, Rodney Macedo. 2024; 388: 20.
https://doi.org/10.1016/bs.ircmb.2024.02.003 |
| 6 |
2024 |
丽葶 黄, The Role of MDSCs in Digestive System Tumors and Research Progress in Targeted Therapy, Advances in Clinical Medicine. 2024; 14: 925.
https://doi.org/10.12677/acm.2024.1492548 |
| 7 |
2025 |
David L. Drum, Anika G. Jallorina, Leo S. Wan, Victor T. Chang, Mary F. Lee‐Wong. Non‐Genetic Biomarkers in Merkel Cell Carcinoma: Prognostic Implications and Predictive Utility for Response to Anti‐PD‐(L)1 Immune Checkpoint Inhibitors, Experimental Dermatology. 2025; 34: e70030.
https://doi.org/10.1111/exd.70030 |
